Although these results demonstrated the prognostic potential of the Ror2/Wnt module gene signature, the study of Venet et al. (64) has suggested that also random gene signatures are able to separate breast cancer patient into groups with significantly different outcomes. This evidence concerns the gene ROR2 and breast cancer.